Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer
Clinical trial NCT00504790 · COMPLETED
Trial details
- NCT number
- NCT00504790
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-25
- Primary completion
- 2012-05-07
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.